Zobrazeno 1 - 5
of 5
pro vyhledávání: '"PD, progression disease"'
Autor:
Jia-Tao Zhang, Jian Su, Hai-Yan Tu, Hao Sun, Xu-Chao Zhang, Zhi-Hong Chen, Jin-Ji Yang, Qing Zhou, Yi-Long Wu, Jia-Ying Zhou, Si-Yang Maggie Liu, Kai Yin
Publikováno v:
Translational Oncology
Translational Oncology, Vol 15, Iss 1, Pp 101254-(2022)
Translational Oncology, Vol 15, Iss 1, Pp 101254-(2022)
Highlights • Predictive power of PD response for ICIs was superior than traditional biomarkers; • Predictive efficacy was improved by integrating tumor-immune-related features; • When tumor-specific feature was replaced, the model has pan-cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daad381fb5c7640d53e71e4388f09e65
https://doi.org/10.1016/j.tranon.2021.101254
https://doi.org/10.1016/j.tranon.2021.101254
Autor:
Tatsuya Yoshida, Yasushi Rino, Takashi Yamanaka, Toshinari Yamashita, Haruhiko Yamazaki, Satoru Shimizu, Munetaka Masuda, Nobuyasu Suganuma
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Undifferentiated pleomorphic sarcoma constitutes
Introduction Undifferentiated pleomorphic sarcoma (UPS) constitutes less than of all sarcomas in adults and rarely involves the breast. We herein present a patient with UPS of the b
Introduction Undifferentiated pleomorphic sarcoma (UPS) constitutes less than of all sarcomas in adults and rarely involves the breast. We herein present a patient with UPS of the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40420bb12e93d1774441a2e873833379
https://doi.org/10.1016/j.ijscr.2018.07.049
https://doi.org/10.1016/j.ijscr.2018.07.049
Autor:
Junping Zhang, Ruixing Zhang, Ningning Li, Lin Zhao, Chunmei Bai, Zhanzhao Fu, Xiubao Ren, Liwen Ma
Publikováno v:
Translational Oncology, Vol 14, Iss 2, Pp 101004-(2021)
Translational Oncology
Translational Oncology
Highlight • Apatinib showed promising efficacy and an acceptable safety profile in patients with advanced AFPGC. • Based on the higher expression of VEGF-C of AFPGC compared with common GC, application of antiangiogenic therapy may be a profitabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f609281268ce691cd18df6b65ac3212e
https://doi.org/10.1016/j.tranon.2020.101004
https://doi.org/10.1016/j.tranon.2020.101004
Autor:
Yang D; Department of Respiratory Diseases, People's Hospital of Tongling, Tongling, China., Dai R; Department of Respiratory Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhang Q; Center for Cancer Research, National Cancer Institute, National Institutes of Health, USA., Fang P; Department of Respiratory Diseases, People's Hospital of Tongling, Tongling, China.
Publikováno v:
Saudi journal of biological sciences [Saudi J Biol Sci] 2018 Jul; Vol. 25 (5), pp. 888-894. Date of Electronic Publication: 2017 Dec 27.
Autor:
Mangia A; a Functional Biomorphology Laboratory ; National Cancer Research Centre ; Istituto Tumori 'Giovanni Paolo II'; Bari , Italy., Caldarola L, Dell'Endice S, Scarpi E, Saragoni L, Monti M, Santini D, Brunetti O, Simone G, Silvestris N
Publikováno v:
Cancer biology & therapy [Cancer Biol Ther] 2015; Vol. 16 (8), pp. 1140-7. Date of Electronic Publication: 2015 Jun 30.